Please assess the completion status of the following clinical trial:

Trial Title: Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Patient must fulfill El Escorial criteria (APPENDIX 2) for definite or probable ALS (sporadic and not familial)~2. Participants, either men or non pregnant women are between 20 and 75 years of age.~3. The patient is mentally intact and psychologically stable~4. Patients will be with an ALS-FRS-R scale (APPENDIX 3) of at least 30 and disease duration of less than 2 years.~5. Patient has sufficiently bulky muscles.~6. Participant understands the nature of the procedure and provides written informed consent prior to any study procedure.~Exclusion Criteria:~1. Patient has a positive test for HBV, HCV or HIV.~2. Patient has high protein in the CSF (Protein \> 70 mg/ml).~3. Patient has lymphocytosis in the CSF (lymphocytes \> 5/ml).~4. Patient is positive for anti-GM1 antibodies.~5. Patient has significant conduction blocks or slow nerve conduction velocities (a reduction of more than 30%) confirmed by nerve conduction velocity - EMG studies.~6. The patient is a respiratory dependent patient.~7. Patients with renal failure (Cr \> 2 mg/dl).~8. Patients with impaired hepatic function (ALT, AST or GGT 2-fold higher than normal upper limit).~9. Patients suffering from significant cardiac disease, malignant disease or any other disease that may risk the patient or interfere with the ability to interpret the results~10. Patient with active infections.~11. Participation in another clinical trial within 1 month prior to start of this study.~12. Patient has not been treated previously with any cellular therapy.~13. Subject unwilling or unable to comply with the requirements of the protocol.

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- MSC-NTF (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).